August 13, 2022
1 min read
The Parker Institute for Cancer Immunotherapy presented $4.5 million in fellowship and scholarship awards to nine graduate and postdoctoral researchers.
The awards bring to more than $19 million the amount awarded through its early career research program, which started in 2016.
“The 2022 awardees, like those who have come before them, are among the best and brightest minds anywhere,” John Connolly, PhD, chief scientific officer at Parker Institute for Cancer Immunotherapy, said in a press release. “We are proud to support these researchers, who are dedicated to innovating our approach to cancer to improve patient outcomes.”
Parker Institute partnered with the V Foundation for Cancer Research to fund for of this year’s awards, known as Parker Bridge Fellows. The four recipients are senior postdoctoral investigators whose research is designed to answer critical questions in cancer immunotherapy.
The recipients are Katie Campbell, PhD, of University of California, Los Angeles; Kenneth Hu, PhD, of University of California, San Francisco; Derek Oldridge, MD, PhD, of University of Pennsylvania; and Bingfei Yu, PhD, of Stanford Medicine.
An anonymous donor committed funding to create the Parker RISE Scholar award, presented to Gabriel Abril Rodriguez, PhD, postdoctoral researcher at UCLA.
This year’s Parker Senior Fellow — a senior researcher who recently earned an MD or PhD degree and is ready to establish a laboratory or independent program in cancer immunotherapy — is Ya-Ting (Emma) Wang, PhD, of Memorial Sloan Kettering Cancer Center.
This year’s Parker Scholars – graduate students and researchers focused on high-impact projects who are entering their first postdoctoral appointments — are Inaki Etxeberria, PhD, of Memorial Sloan Kettering Cancer Center; Louai Labanieh, PhD, of Stanford Medicine; and Darwin Ye, doctoral candidate at University of Pennsylvania.